This article is part of the supplement: Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma
Review
Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings
-
* Corresponding author: R Michael Grounds m.grounds@blueyonder.co.uk
Critical Care 2005, 9(Suppl 5):S29-S36 doi:10.1186/cc3783
No comments have yet been made on this article.